SubjectVerb relationObjectSentenceSentimentTitleUrlDate
ISTANBUL Battling sharp rise in food costs Turkish authorities opened their own markets on Monday to sell cheap vegetables directly to shoppers cutting out retailers who government has accused of jacking up prices ISTANBUL Battling a sharp rise in food costs Turkish authorities opened their own markets on Monday to sell cheap vegetables directly to shoppers cutting out retailers who the government has accused of jacking up prices NegativeISTANBUL Battling a sharp rise in food costs Turkish authorities opened their own markets on Monday to sell cheap vegetables directly to shoppers cutting out retailers who the government has accused of jacking up prices http://www.reuters.com/subjects/middle-easthttps://www.reuters.com/article/us-turkey-economy-inflation/turkey-opens-government-vegetable-stalls-in-battle-with-inflation-idUSKCN1Q01TN2019-02-12
MMB sells genetically modified cotton seeds under license to nearly 40 Indian seed companies which in turn sell products to retailers MMB sells genetically modified cotton seeds under license to nearly 40 Indian seed companies which in turn sell the products to retailers NeutralNEW DELHI German drugmaker Bayer AGs Monsanto unit has won proceedings against Indian seed maker Nuziveedu Seeds Ltd in a royalty dispute lawyers familiar with the matter said http://www.reuters.com/finance/article/us-india-monsanto-exclusive/exclusive-bayers-monsanto-wins-arbitration-ruling-over-royalties-from-indian-seed-company-idUSKCN1Q01ZF2019-02-12
25 billion buy of Bemis after agreeing to sell U.S. companys medical packaging business in Europe to address competition concerns 25 billion buy of Bemis after agreeing to sell the U.S. companys medical packaging business in Europe to address competition concerns PositiveBRUSSELS Australian packaging company Amcor secured EU antitrust approval on Monday for its http://www.reuters.com/finance/dealshttps://www.reuters.com/article/us-bemis-m-a-amcor-eu/amcor-wins-conditional-eu-approval-for-5-25-billion-bemis-buy-idUSKCN1Q01SG2019-02-12
Buyout group EQT is set to sell 20 percent to 25 percent stake in Independent Vetcare Group to institutional investors in deal that will value one of Europes biggest veterinary services providers at over 1 Buyout group EQT is set to sell a 20 percent to 25 percent stake in Independent Vetcare Group to institutional investors in deal that will value one of Europes biggest veterinary services providers at over 1 PositiveBuyout group EQT is set to sell a 20 percent to 25 percent stake in Independent Vetcare Group to institutional investors in deal that will value one of Europes biggest veterinary services providers at over 1 http://www.reuters.com/finance/dealshttps://www.reuters.com/article/us-ivc-fundraise/swedish-buyout-group-eqt-to-sell-stake-in-pet-care-group-ivc-sources-idUSKCN1Q022N2019-02-12
Norwegian bank DNB still plans to sell its 20percent stake in stock market operator Oslo Bors VPS to Nasdaq despite higher bid by Euronext bank said Norwegian bank DNB still plans to sell its 20percent stake in stock market operator Oslo Bors VPS to Nasdaq despite a higher bid by Euronext the bank said NegativeAmcor http://www.reuters.com/finance/markets/article/deals-day/deals-of-the-day-mergers-and-acquisitions-idUSL3N2061SE2019-02-12
German brewers Radeberger and Veltins to set up joint venture to distribute and sell their beers Jan German brewers Radeberger and Veltins to set up a joint venture to distribute and sell their beers Jan PositiveBRUSSELS Feb 11 The following are mergers under review by the European Commission and a brief guide to the EU merger http://www.reuters.com/news/mediahttps://www.reuters.com/article/eu-ma/eu-mergers-and-takeovers-idUSL5N2064T92019-02-12
Floridabased Catalyst which in November received U.S. approval to sell drug set list price of year Floridabased Catalyst which in November received U.S. approval to sell the drug set a list price of a year NegativeNEW YORK Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease which had long been available to patients for free will cost more than per year including rebates to insurers and other discounts http://www.reuters.com/news/health/article/us-catalyst-pharms-drugpricing/catalyst-pharma-sees-net-price-of-drug-once-free-topping-300000-idUSKCN1Q02862019-02-12